Management of Brain Metastases in Melanoma | Overview
The management of melanoma patients with brain metastases has changed rapidly in the last five years, and patients now have much-improved survival rates. Brain metastases are no longer a death sentence and many people can have control of their disease with quality life. In this podcast, Medical Oncologist A/Prof Alex Menzies, Neurosurgeon Dr Brindha Shivalingam and Radiation Oncologist Prof Angela Hong discuss the contemporary multidisciplinary management of patients with brain metastases and through examining two case studies, they discern the factors that need to be considered for deciding best practice. This podcast is suitable for medical oncologists, rural oncologists, radiation oncologists, surgeons (including neurosurgeons), and may also be of interest to GPs, oncology nurses and other healthcare practitioners.
Subscribe to our new Melanoma Insights for Professionals podcasts via iTunes or Spotify or for Android devices, click here or search for 'Melanoma Insights for Professionals' your favourite podcast app.
A/Prof Alexander Menzies
Medical Oncologist, Melanoma Institute Australia, Royal North Shore and Mater Hospitals Associate Professor of Melanoma Medical Oncology, The University of Sydney
Dr Bringha Shivalingam
Director of Neurosurgery, The Chris O’Brien Lifehouse | Consultant Neurosurgeon, Royal Prince Alfred Hospital and The Mater Hospital Associate, Melanoma Institute Australia
Prof Angela Hong
Radiation Oncologist, Melanoma Institute Australia, The Mater Hospital and Chris O’Brien Lifehouse Clinical Professor, The University of Sydney
1. Outline the role of systemic therapy in the treatment of brain metastases.
2. Recall the role that neurosurgery plays in treatment of brain metastases and identify when it is an appropriate treatment modality.
3. Identify when opportunities exist for radiotherapy in the treatment and palliation of patients with brain metastases.